Boehringer Ingelheim International
- A03 - Agentes contra padecimientos funcionales del estómago e intestino
- BUSCOPAN coated tablet 10 mg
- BUSCOPAN solution for injection 20 mg/1 ml
- A06 - Agentes contra el estreñimiento
- DULCOLAX suppository 10 mg
- LAXOBERAL oral drops, solution 7.5 mg/ml
- A10 - Antidiabéticos
- TRAJENTA film-coated tablet 5 mg
- B01 - Agentes antitrombóticos
- ACTILYSE powder and solvent for solution for injection 50 mg+50 ml
- METALYSE powder and solvent for solution for injection 10 000 IU(50 mg)+10 ml
- PERSANTIN coated tablet 100 mg
- PERSANTIN RETARD prolonged-release capsule, hard 200 mg
- PRADAXA capsule, hard 110 mg
- PRADAXA capsule, hard 150 mg
- PRADAXA capsule, hard 75 mg
- C02 - Antihipertensivos
- CATAPRESAN tablet 0.075 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- MICARDIS PLUS tablet 80 mg+12.5 mg
- MICARDIS tablet 40 mg
- MICARDIS tablet 80 mg
- J05 - Antivirales de uso sistémico
- APTIVUS capsule, soft 250 mg
- VIRAMUNE prolonged-release tablet 400 mg
- VIRAMUNE tablet 200 mg
- N04 - Antiparkinsonianos
- SIFROL prolonged-release tablet 0.26 mg
- SIFROL prolonged-release tablet 0.52 mg
- SIFROL prolonged-release tablet 2.1 mg
- SIFROL tablet 0.088 mg
- SIFROL tablet 0.18 mg
- SIFROL tablet 0.7 mg
- R01 - Preparaciones nasales
- ATROVENT nasal spray, solution 21 µg/dose
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- ATROVENT nebuliser solution 0.25 mg/1 ml
- ATROVENT pressurised inhalation, suspension 20 µg/dose
- SPIRIVA inhalation powder, hard capsule 18 µg
- SPIRIVA RESPIMAT pressurised inhalation, solution 2.5 µg/dose
- STRIVERDI RESPIMAT pressurised inhalation, solution 2.5 µg